Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Go back to Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
(NASDAQ: INBS) Delayed: 2.36 +0.07 (3.06%)
Previous Close $2.29    52 Week High
Open $2.35    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.35    EPS
Volume 9,342       

(NASDAQ: INBS) Delayed: 2.36 +0.07 (3.06%)
Previous Close $2.29    52 Week High
Open $2.35    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.35    EPS
Volume 9,342